TGTXTG THERAPEUTICS, INC.

Nasdaq tgtherapeutics.com


$ 13.32 $ -0.15 (-1.11 %)    

Monday, 29-Apr-2024 15:59:51 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 13.32
$ 13.57
$ 0.00 x 0
$ 0.00 x 0
$ 13.24 - $ 13.82
$ 6.46 - $ 35.67
2,879,612
na
1.98B
$ 2.10
$ 156.10
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-06-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-08-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-02-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 05-10-2019 10-Q
21 03-01-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-15-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-16-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-15-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 07-24-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-45-price-target

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...

 jp-morgan-reiterates-overweight-on-tg-therapeutics-maintains-25-price-target

JP Morgan analyst Eric Joseph reiterates TG Therapeutics (NASDAQ:TGTX) with a Overweight and maintains $25 price target.

 ladenburg-thalmann-reiterates-buy-on-tg-therapeutics-maintains-39-price-target

Ladenburg Thalmann analyst Matthew Kaplan reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $39 price target.

 tg-therapeutics-inc-awarded-186776520-contract-from-department-of-veterans-affairs-nac-pharmaceuticals-for-pharmaceutical-preparation-manufacturing-6505--anti-cd20-antibodies

https://sam.gov/opp/5efea17b278941f7ae9ba627116a29be/view 

 hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-45-price-target

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...

 goldman-sachs-maintains-neutral-on-tg-therapeutics-raises-price-target-to-13

Goldman Sachs analyst Corinne Jenkins maintains TG Therapeutics (NASDAQ:TGTX) with a Neutral and raises the price target fro...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-is-multiple-sclerosis-focused-tg-therapeutics-stock-trading-higher-today

TG Therapeutics exceeds expectations with Q4 2023 revenues of $43.97M. Briumvi's success in the U.S., Europe launch, and ne...

 hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-45-price-target

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...

 advance-auto-parts-reports-q4-results-joins-bg-foods-vipshop-adt-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Wednesday.

 tg-therapeutics-q4-2023-adj-eps-009-beats-010-estimate-sales-4397m-beat-4006m-estimate

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.1...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION